These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24281780)

  • 1. Calcineurin activity assay measurement by liquid chromatography-tandem mass spectrometry in the multiple reaction monitoring mode.
    Carr L; Gagez AL; Essig M; Sauvage FL; Marquet P; Gastinel LN
    Clin Chem; 2014 Feb; 60(2):353-60. PubMed ID: 24281780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of calcineurin activity in peripheral blood mononuclear cells by ultra-high performance liquid chromatography-tandem mass spectrometry. Renal transplant recipients application (pharmacodynamic monitoring).
    Fontova P; Rigo-Bonnin R; Vidal-Alabró A; Cerezo G; Bestard O; Cruzado JM; Torras J; Grinyó JM; Lloberas N
    Clin Chim Acta; 2019 Aug; 495():287-293. PubMed ID: 31039337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-blood calcineurin activity is not predicted by cyclosporine blood concentration in renal transplant recipients.
    Caruso R; Perico N; Cattaneo D; Piccinini G; Bonazzola S; Remuzzi G; Gaspari F
    Clin Chem; 2001 Sep; 47(9):1679-87. PubMed ID: 11514403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in leukocyte subset concentrations affects calcineurin activity measurement: implications for pharmacodynamic monitoring strategies.
    van Rossum HH; Romijn FP; Sellar KJ; Smit NP; van der Boog PJ; de Fijter JW; van Pelt J
    Clin Chem; 2008 Mar; 54(3):517-24. PubMed ID: 18218723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A transient increase of calcineurin phosphatase activity in living-donor kidney transplant recipients with acute rejection.
    Fukudo M; Yano I; Katsura T; Ito N; Yamamoto S; Kamoto T; Ogawa O; Inui K
    Drug Metab Pharmacokinet; 2010; 25(5):411-7. PubMed ID: 20834189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous measurement of cyclosporin A and tacrolimus from dried blood spots by ultra high performance liquid chromatography tandem mass spectrometry.
    Hinchliffe E; Adaway JE; Keevil BG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 883-884():102-7. PubMed ID: 21680259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic monitoring of calcineurin phosphatase activity in transplant patients treated with calcineurin inhibitors.
    Yano I
    Drug Metab Pharmacokinet; 2008; 23(3):150-7. PubMed ID: 18574318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients.
    Fukudo M; Yano I; Masuda S; Fukatsu S; Katsura T; Ogura Y; Oike F; Takada Y; Tanaka K; Inui K
    Clin Pharmacol Ther; 2005 Aug; 78(2):168-81. PubMed ID: 16084851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in peripheral blood mononuclear cells.
    Capron A; Musuamba F; Latinne D; Mourad M; Lerut J; Haufroid V; Wallemacq PE
    Ther Drug Monit; 2009 Apr; 31(2):178-86. PubMed ID: 19057467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrophotometric assay for calcineurin activity in leukocytes isolated from human blood.
    Sellar KJ; van Rossum HH; Romijn FP; Smit NP; de Fijter JW; van Pelt J
    Anal Biochem; 2006 Nov; 358(1):104-10. PubMed ID: 16979577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An UPLC-MS/MS method coupled with automated on-line SPE for quantification of tacrolimus in peripheral blood mononuclear cells.
    Pensi D; De Nicolò A; Pinon M; Calvo PL; Nonnato A; Brunati A; Di Perri G; D'Avolio A
    J Pharm Biomed Anal; 2015 Mar; 107():512-7. PubMed ID: 25698619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a novel commercial assay for the determination of cyclosporine A, tacrolimus, sirolimus, and everolimus by liquid chromatography-tandem mass spectrometric assay.
    Becker S; Thiery J; Ceglarek U
    Ther Drug Monit; 2013 Feb; 35(1):129-32. PubMed ID: 23188181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid determination of immunosuppressive drug concentrations in whole blood by coated blade spray-tandem mass spectrometry (CBS-MS/MS).
    Gómez-Ríos GA; Tascon M; Reyes-Garcés N; Boyacı E; Poole JJ; Pawliszyn J
    Anal Chim Acta; 2018 Jan; 999():69-75. PubMed ID: 29254576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic monitoring of calcineurin inhibitors for the nephrologist.
    Schiff J; Cole E; Cantarovich M
    Clin J Am Soc Nephrol; 2007 Mar; 2(2):374-84. PubMed ID: 17699437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of the HIV-integrase inhibitor raltegravir and detection of its main metabolite in human plasma, dried blood spots and peripheral blood mononuclear cell lysate by means of high-performance liquid chromatography tandem mass spectrometry.
    Ter Heine R; Hillebrand MJ; Rosing H; van Gorp EC; Mulder JW; Beijnen JH; Huitema AD
    J Pharm Biomed Anal; 2009 Feb; 49(2):451-8. PubMed ID: 19128911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative determination of four immunosuppressants by high resolution mass spectrometry (HRMS).
    Bruns K; Mönnikes R; Lackner KJ
    Clin Chem Lab Med; 2016 Jul; 54(7):1193-200. PubMed ID: 26641969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter evaluation of the thermo scientific prelude for measurement of immunosuppressant drugs using sample preparation liquid chromatography-tandem mass spectrometry.
    Peake RW; Hartigan CR; Esposito CL; Kellogg MD; Gabler J; Wang S; Breaud A; Di Bussolo J; Moskowitz J; Clarke W
    Ther Drug Monit; 2015 Apr; 37(2):161-71. PubMed ID: 25072947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.
    Ventura E; Bonardet A; Pageaux GP; Mourad G; Cristol JP
    Transplant Proc; 2009 Mar; 41(2):707-9. PubMed ID: 19328963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The calcineurin activity profiles of cyclosporin and tacrolimus are different in stable renal transplant patients.
    Koefoed-Nielsen PB; Karamperis N; Højskov C; Poulsen JH; Jørgensen KA
    Transpl Int; 2006 Oct; 19(10):821-7. PubMed ID: 16961774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between calcineurin inhibition and plasma endothelin concentrations in cyclosporine-A-treated kidney transplant patients.
    Büchler M; Leibenguth P; Le Guellec C; Carayon A; Watier H; Odoul F; Autret-Leca E; Lebranchu Y; Paintaud G
    Eur J Clin Pharmacol; 2004 Dec; 60(10):703-8. PubMed ID: 15619133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.